Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
221.00    -0.50 (-0.23%)
Bid:
220.50
Ask:
221.50
Spread: 1.00 (0.454%)
Market Cap: £610.88m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Director/PDMR Shareholding - Amendment

13 Apr 2010 11:34

RNS Number : 0961K
Morgan Crucible Co PLC
13 April 2010
 



 

The Morgan Crucible Company plc

 

Amendment - PDMR Transactions relating to The Morgan Crucible Bonus Deferral Share Matching Plan (the 'Plan')

 

13th April 2010

 

 

1. Deferred Awards granted under the Plan in March and April 2008

 

Due to an administrative error, the Shares sold to discharge tax in Column 3 in the table below and the net number of Restricted Shares in Column 4 in the table below were incorrectly stated for each participant in an announcement made on 18th March 2010. The correct numbers are now set out below.

 

As detailed in the previous announcement, on 18th March 2010 the PDMRs and Executive Directors listed below waived certain Deferred Awards that were granted to them on 11th March 2008 and 18th April 2008 respectively. On the same date these persons were granted awards over an equivalent number of restricted Shares, which will attract matching Shares if retained until the original vesting date of the Deferred Awards.

 

The number of restricted Shares was increased to reflect the notional re-investment of dividends on the waived Deferred Awards.

 

Each participant sold a portion of their restricted Shares to satisfy the income tax and employee national insurance due under the arrangements.

 

The number of matching Shares, linked to the Deferred Awards, remained unchanged.

 

 

1

2

3

4

Executive

 

Number of Shares waived under 2008 Deferred Award

Number of Shares granted under restricted Share Award

Shares sold to discharge tax (1)

Net number of Restricted Shares held - as amended

Paul Boulton

36,685

40,895

16,843

24,052

Kevin Dangerfield

58,266

64,953

26,751

38,202

Ralph Gomarsall

26,565

29,613

12,197

17,416

Simon Halliday

24,766

27,607

11,370

16,237

Tim Hayter

50,600

56,406

23,232

33,174

Andrew Hosty

53,652

59,808

24,633

35,175

Andrew Riley

8,777

9,782

4,030

5,752

Mark Robertshaw

104,743

116,765

48,090

68,675

Amanda Wooding

34,155

38,074

15,682

22,392

 

(1) The sale of Shares (to satisfy the tax and employee national insurance contributions falling due and to cover the incidental costs of disposal) took place on the London Stock Exchange on 18th March 2010, at a price of 188p per Share.

 

2. Shareholdings following the above amendments

 

As a result of the amendments detailed above, the total shareholdings and total percentage holdings of the executives listed above are as follows:

Executive

Shareholding (including shares held as post-tax Deferred Awards under the Plan)

Total Percentage Holding

Paul Boulton

24,095

0.0089%

Kevin Dangerfield

191,089

0.0707%

Ralph Gomarsall

75,402

0.0279%

Simon Halliday

98,776

0.0365%

Tim Hayter

108,246

0.04%

Andrew Hosty

277,230

0.1026%

Andrew Riley

78,414

0.029%

Mark Robertshaw

476,809

0.1764%

Amanda Wooding

42,787

0.0158%

 

This notification relates to transactions notified in accordance with DR 3.1.4R (1) (a).

 

Enquiries: Tracey Bigmore, The Morgan Crucible Company plc

Tel: 01753 837000

 

Date of notification: 13th April 2010

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGCGDSDUBBGGX
Date   Source Headline
26th Sep 202312:24 pmRNSDirector/PDMR Shareholding
16th Aug 202311:27 amRNSDirector/PDMR Shareholding
7th Aug 20235:24 pmRNSDirector/PDMR Shareholding
4th Aug 20237:00 amRNSHalf-Year Results for Period Ended 30 June 2023
13th Jul 20234:49 pmRNSDirector/PDMR Shareholding
5th Jul 20234:51 pmRNSDirector/PDMR Shareholding
29th Jun 20235:06 pmRNSResult of AGM
29th Jun 20237:00 amRNSH1 Trading Update
22nd Jun 202311:50 amRNSBlock listing Interim Review
31st May 20233:52 pmRNSDirector/PDMR Shareholding
26th May 20233:28 pmRNSNotice of Annual General Meeting 2023
24th May 20233:59 pmRNSDirector/PDMR Shareholding
11th May 202312:06 pmRNSDirector/PDMR Shareholding
11th May 202312:01 pmRNSDirector/PDMR Shareholding
11th May 202311:59 amRNSDirector/PDMR Shareholding
9th May 20235:59 pmRNSDirector/PDMR Shareholding
4th May 20235:28 pmRNSAnnual Report & Accounts 2022
3rd May 20235:38 pmRNSDirector/PDMR Shareholding
3rd May 20235:28 pmRNSDirector/PDMR Shareholding
28th Apr 20235:45 pmRNSInformation required by DTR 4.1
28th Apr 20237:00 amRNSFull-year results for the period ended 31 Dec 2022
13th Apr 20237:00 amRNSNotification of Full-Year Results
7th Feb 20237:00 amRNSUpdate on Trading and Cyber Security Incident
18th Jan 20237:00 amRNSAppointment of Chair Designate
10th Jan 20237:00 amRNSNotice of Cyber Security Incident
22nd Dec 202211:01 amRNSBlock listing Interim Review
16th Dec 20224:44 pmRNSHolding(s) in Company
6th Dec 20227:00 amRNSAccelerated Pension Contribution
6th Dec 20227:00 amRNSCapital Markets Event
23rd Nov 202210:01 amRNSDirector/PDMR Shareholding
15th Nov 20225:06 pmRNSDirector/PDMR Shareholding
10th Nov 20228:03 amRNSDirector Declaration
4th Nov 20227:00 amRNSTrading Update
17th Oct 20222:21 pmRNSDirector/PDMR Shareholding
26th Sep 202212:52 pmRNSDirector/PDMR Shareholding
26th Sep 202212:49 pmRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSHalf-year results
15th Jun 20229:30 amRNSBlock listing Interim Review
1st Jun 202210:00 amRNSDirector/PDMR Shareholding
31st May 202210:06 amRNSDirector/PDMR Shareholding
24th May 20222:32 pmRNSDirector/PDMR Shareholding
16th May 20222:52 pmRNSDirector/PDMR Shareholding
5th May 20223:12 pmRNSDirectorate Change
5th May 20222:00 pmRNSResult of AGM
5th May 20227:00 amRNSQ1 trading update
3rd May 20222:45 pmRNSHolding in Company
14th Apr 20222:59 pmRNSHolding(s) in Company
30th Mar 20223:25 pmRNSAnnual Financial Report
28th Mar 202212:00 pmRNSHolding in Company
23rd Mar 202211:02 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.